Literature DB >> 2835018

Epstein-Barr virus infection and autoimmunity in rheumatoid arthritis.

P Venables1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 2835018      PMCID： PMC1003505          DOI： 10.1136/ard.47.4.265

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  28 in total

1.  Cryoenzymology in aqueous media: Micellar solubilized water clusters.

Authors:  P Douzou; E Keh; C Balny
Journal:  Proc Natl Acad Sci U S A       Date:  1979-02       Impact factor: 11.205

2.  Reaction of antibodies to rheumatoid arthritis nuclear antigen with a synthetic peptide corresponding to part of Epstein-Barr nuclear antigen 1.

Authors:  P J Venables; T Pawlowski; P A Mumford; C Brown; D H Crawford; R N Maini
Journal:  Ann Rheum Dis       Date:  1988-04       Impact factor: 19.103

3.  Persistence of Epstein-Barr virus in the parotid gland.

Authors:  H Wolf; M Haus; E Wilmes
Journal:  J Virol       Date:  1984-09       Impact factor: 5.103

4.  Lymphoblastoid cell lines and Burkitt-lymphoma-derived cell lines differ in the expression of a second Epstein-Barr virus encoded nuclear antigen.

Authors:  I Ernberg; B Kallin; J Dillner; K Falk; B Ehlin-Henriksson; M L Hammarskjöld; G Klein
Journal:  Int J Cancer       Date:  1986-11-15       Impact factor: 7.396

5.  Antibody to the rheumatoid arthritis nuclear antigen. Its relationship to in vivo Epstein-Barr virus infection.

Authors:  M A Catalano; D A Carson; J C Niederman; P Feorino; J H Vaughan
Journal:  J Clin Invest       Date:  1980-05       Impact factor: 14.808

6.  Correlation between the presence of antibodies to the Epstein-Barr virus nuclear antigen type 2 and antibodies to the rheumatoid arthritis nuclear antigen in patients with rheumatoid arthritis.

Authors:  T B Sculley; J H Pope; R A Hazelton
Journal:  Arthritis Rheum       Date:  1986-08

7.  A search for rheumatoid arthritis-associated nuclear antigen and Epstein-Barr virus specific antigens or genomes in tissues and cells from patients with rheumatoid arthritis.

Authors:  M A Alspaugh; H Shoji; M Nonoyama
Journal:  Arthritis Rheum       Date:  1983-06

8.  Anti-intermediate filament antibodies, antikeratin antibody, and antiperinuclear factor in rheumatoid arthritis and infectious mononucleosis.

Authors:  P K Kataaha; S M Mortazavi-Milani; G Russell; E J Holborow
Journal:  Ann Rheum Dis       Date:  1985-07       Impact factor: 19.103

9.  Antibodies to the Epstein-Barr virus nuclear antigen and to rheumatoid arthritis nuclear antigen identify the same polypeptide.

Authors:  P B Billings; S O Hoch; P J White; D A Carson; J H Vaughan
Journal:  Proc Natl Acad Sci U S A       Date:  1983-12       Impact factor: 11.205

10.  Antibodies to extractable nuclear antigens in rheumatoid arthritis: relationship to vasculitis and circulating immune complexes.

Authors:  P J Venables; C C Erhardt; R N Maini
Journal:  Clin Exp Immunol       Date:  1980-01       Impact factor: 4.330
View more
  12 in total

1.  Cross reaction of antibodies to a glycine/alanine repeat sequence of Epstein-Barr virus nuclear antigen-1 with collagen, cytokeratin, and actin.

Authors:  C Baboonian; P J Venables; D G Williams; R O Williams; R N Maini
Journal:  Ann Rheum Dis       Date:  1991-11       Impact factor: 19.103

2.  Differential immunological response of patients with rheumatoid arthritis towards two different Epstein-Barr virus strains: inhibition of interleukin-1 release by the B95-8, but not the P3HR-1 virus strain.

Authors:  T Häupl; G R Burmester; G Hahn; U Feige; C Rordorf-Adam; J R Kalden
Journal:  Rheumatol Int       Date:  1989       Impact factor: 2.631

3.  Anti-cardiolipin antibodies in infectious mononucleosis react with the membrane of activated lymphocytes.

Authors:  R Misra; P J Venables; C Plater-Zyberk; P F Watkins; R N Maini
Journal:  Clin Exp Immunol       Date:  1989-01       Impact factor: 4.330

4.  Absence of Epstein-Barr virus carrying cells in synovial membranes and subcutaneous nodules of patients with rheumatoid arthritis.

Authors:  P Brousset; M Caulier; A Cantagrel; C Dromer; B Mazières; G Delsol
Journal:  Ann Rheum Dis       Date:  1993-08       Impact factor: 19.103

Review 5.  The Epstein-Barr virus in autoimmunity.

Authors:  J H Vaughan
Journal:  Springer Semin Immunopathol       Date:  1995

Review 6.  Role of immunity to mycobacterial stress proteins in rheumatoid arthritis.

Authors:  L McLean; V Winrow; D Blake
Journal:  J Exp Pathol (Oxford)       Date:  1990-04

7.  Purification and partial sequencing of the nuclear autoantigen RA33 shows that it is indistinguishable from the A2 protein of the heterogeneous nuclear ribonucleoprotein complex.

Authors:  G Steiner; K Hartmuth; K Skriner; I Maurer-Fogy; A Sinski; E Thalmann; W Hassfeld; A Barta; J S Smolen
Journal:  J Clin Invest       Date:  1992-09       Impact factor: 14.808

8.  Auranofin inhibits calcium uptake into opsonized-zymosan-stimulated neutrophils obtained from rats.

Authors:  K Ishitani; A Matsuura; H Honda
Journal:  Inflamm Res       Date:  1995-11       Impact factor: 4.575

Review 9.  The cancer stem cell: evidence for its origin as an injured autoreactive T cell.

Authors:  Peter Grandics
Journal:  Mol Cancer       Date:  2006-02-14       Impact factor: 27.401

10.  T cell response to Epstein-Barr virus transactivators in chronic rheumatoid arthritis.

Authors:  E Scotet; J David-Ameline; M A Peyrat; A Moreau-Aubry; D Pinczon; A Lim; J Even; G Semana; J M Berthelot; R Breathnach; M Bonneville; E Houssaint
Journal:  J Exp Med       Date:  1996-11-01       Impact factor: 14.307
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.